ArticleBone marrow transplantation2021

Venetoclax-based salvage therapy followed by Venetoclax and DLI maintenance vs. FLAG-Ida for relapsed or refractory acute myeloid leukemia after allogeneic stem cell transplantation.

Andrius Zucenka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.